Please check your internet connection and try again.
# Pantoprazole
## Overview
Pantoprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by irreversibly inhibiting the H+/K+-ATPase enzyme system in gastric parietal cells.
## Primary Indications
* Healing of erosive esophagitis associated with gastroesophageal reflux disease (GERD)
* Maintenance of healing of erosive esophagitis
* Treatment of pathological hypersecretory conditions, such as Zollinger-Ellison syndrome
## Adult Dosing
* **Erosive esophagitis:** 40 mg orally or intravenously once daily for up to 8 weeks. A subsequent 8-week course may be indicated for patients who have not healed.
* **Maintenance of healing of erosive esophagitis:** 40 mg orally once daily.
* **Pathological hypersecretory conditions:** Starting dose is typically 40 mg orally or intravenously twice daily. Doses may be increased as clinically warranted. Doses up to 240 mg IV daily have been administered.
## Pediatric Dosing
* **12 years and older:**
* Erosive esophagitis: 40 mg orally once daily for up to 8 weeks.
* GERD symptoms: 20 mg to 40 mg orally once daily.
* **Less than 12 years:** Dosing varies significantly by indication and weight. Consult specific pediatric guidelines. Safety and efficacy for long-term use beyond 8 weeks in children have not been established.
## Dose Adjustments
* **Hepatic impairment:** For oral formulations, consider reducing the daily dose to 20 mg. IV formulations generally do not require dose adjustment, but caution is advised.
* **Renal impairment:** No dose adjustment is typically needed.
## Contraindications
* Known hypersensitivity to pantoprazole or any component of the formulation.
## Adverse Effects
Common adverse effects include headache, diarrhea, nausea, abdominal pain, vomiting, dizziness, and flatulence. Long-term use of PPIs may be associated with an increased risk of:
* Clostridium difficile-associated diarrhea
* Bone fractures (hip, wrist, spine)
* Hypomagnesemia
* Vitamin B12 deficiency
* Renal impairment
## Key Drug Interactions
* **Drugs requiring gastric acid for absorption:** Pantoprazole can decrease absorption of drugs like ketoconazole, itraconazole, posaconazole, and certain HIV protease inhibitors (e.g., atazanavir, nelfinavir).
* **Methotrexate:** PPIs may increase methotrexate levels.
* **CYP2C19 substrates:** Pantoprazole is a moderate inhibitor of CYP2C19. Caution may be needed with substrates like clopidogrel (though clinical significance is debated).
## Monitoring
* Monitor for signs and symptoms of hypomagnesemia (e.g., muscle spasms, tremors, seizures, arrhythmias).
* Monitor for potential Vitamin B12 deficiency with prolonged therapy.
* Assess for signs of C. difficile infection.
## Clinical Pearls
* Administer oral pantoprazole 30 minutes before a meal.
* IV pantoprazole is a reconstitution and infusion, follow manufacturer's specific instructions.
* For IV administration, the recommended infusion rate is typically over 2 minutes or 15 minutes, depending on concentration and formulation.
* Long-term use should be reserved for appropriate indications, and periodic reassessment of the need for therapy is recommended.
* Consider switching from IV to oral therapy when clinically appropriate.
**Disclaimer:** This information is intended for healthcare professionals. Always consult the current prescribing information and relevant clinical guidelines for complete and up-to-date details before making any treatment decisions.
